Toggle navigation
Home
Search
Services
Blog
Contact
About
Mammalian Cells Expressing Fmo
Crespi, Charles L.
Gentest Corporation, Woburn, MA, United States
Search 27 grants from Charles Crespi
Search grants from Gentest Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Long-acting ghrelin for the treatment of cancer cachexia
Adaptive Treatment Models for the Management of Drug Use Disorders
Retention Time Prediction
Core - Mass Spectrometry Laboratory
Modulation of the Antitumor Effect of Interferon
Recently added grants:
A Wireless, Implantable Microdevice for Closed-Loop Drug Delivery to Prevent the Morbidity of Diabetes Therapy-Induced Hypoglycemia
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology
Genetic Modulators of Glaucoma
Theranostics of Photoreceptor-RPE-Choroid Neurovascular Unit in Mouse Models of Eye Diseases
Advanced Neuroimaging through Novel Encoding Strategies and Hardware Design
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42ES006973-02
Application #
2018491
Study Section
Special Emphasis Panel (ZRG3-SSS-2 (01))
Project Start
1996-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Gentest Corporation
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Related projects
NIH 1997
R42 ES
Mammalian Cells Expressing Fmo
Crespi, Charles L. / Gentest Corporation
NIH 1996
R42 ES
Mammalian Cells Expressing Fmo
Crespi, Charles L. / Gentest Corporation
Comments
Be the first to comment on Charles Crespi's grant